Search

everythinglearnresearchcommunity

for

Search:↓

Stem cell treatment improved life quality and sexual function in women with hair loss.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Finasteride safely treats hair loss without harming hormones or reproduction, but may slightly reduce sexual function.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

The document suggests that finasteride may cause depression and suicidal thoughts, while prostate surgery does not harm sexual health.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

The risks of testosterone implants in women outweigh the benefits.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

New treatments for male hypogonadism are effective and should be personalized.

Medicalization has shaped how society views health and gender roles over the past 200 years.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Taking dutasteride every other day works as well as daily and better preserves sexual function.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Finasteride for female hair loss has low side effects, more research needed.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Core symptoms in breast cancer chemotherapy remain stable, aiding targeted interventions.

Some medications can cause acne, and stopping these drugs is the main treatment.

The article suggests using four questions to tell apart necessary medicalization from excessive medicalization, focusing on problem significance, social expectations, medical understanding, and effective resolution.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.